OCTAGON MEDICAL & SECURITY SOLUTIONS
Octagon Medical & Security Solutions is a medical, rescue, and security provider, offering professional and bespoke services nationwide.
OCTAGON MEDICAL & SECURITY SOLUTIONS
Social Links:
Industry:
First Aid Health Care Medical Security
Founded:
2018-01-01
Address:
Lichfield, Staffordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.omass.co.uk
Total Employee:
1+
Status:
Active
Contact:
01543 226272
Email Addresses:
[email protected]
Similar Organizations
Bjorn Steiger Stiftung
Bjorn Steiger Stiftung is a nonprofit foundation that focuses on emergency aid, ambulance services, and medical assistance.
Pau Hospital Center
Pau Hospital Center is a healthcare sector providing essential and emergency services to patients.
White Star Medical
White Star Medical is providing a professional, safe and efficient solution.
Official Site Inspections
http://www.omass.co.uk
- Host name: jupiter.flipsrv.uk
- IP address: 178.79.157.214
- Location: London United Kingdom
- Latitude: 51.5164
- Longitude: -0.093
- Timezone: Europe/London
- Postal: EC2V
More informations about "Octagon Medical & Security Solutions"
Team - Omass
He founded OMass and served as the first Chief Executive Officer, leading the company through its seed funding and series A financing rounds, allowing OMass to develop its own drug …See details»
OMASS THERAPEUTICS LIMITED overview - Find and update …
More for OMASS THERAPEUTICS LIMITED (10028228) Registered office address Building 4000 John Smith Drive, Oxford Business Park South, Oxford, England, OX4 2GX . Company status …See details»
OMass Therapeutics - Crunchbase Company Profile & Funding
OMass Therapeutics closed its last funding round on May 15, 2023 from a Series B round. Who are OMass Therapeutics 's competitors? Alternatives and possible competitors to OMass …See details»
About OMass Therapeutics - pharmiweb.jobs
Jan 18, 2024 OMass is advancing a pipeline of small molecule therapeutics in rare diseases and immunological conditions, that target solute carriers, complex-bound proteins, and GPCRs. …See details»
Rosamond Deegan, CEO of OMass Therapeutics
Rosamond Deegan is the CEO of OMass Therapeutics which is an Oxford University spin-out supported by Syncona Ltd and Oxford Sciences Innovation. The company uses biophysical technology to push drug discovery for genetic …See details»
OMass Therapeutics (UK) Funding: £128M - medicalstartups.org
Mar 27, 2025 OMass Therapeutics develops new medicines against highly validated but inadequately drugged targets using novel biochemistry techniques, native mass spectrometry …See details»
OMass Therapeutics - VentureRadar
OMass is identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes. We are advancing a pipeline of small molecule …See details»
OMass Technologies - Org Chart, Teams, Culture & Jobs - The Org
View OMass Technologies' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
OMass - Begbroke Science Park
Using this technology allows OMass to interrogate not just the target but how it interacts with its native ecosystem, separate from the confounding complexity of the cell. The company was …See details»
OMass Therapeutics: Creating groundbreaking …
In 2022, OMass was awarded a $100 million investment from an international syndicate, to progress its drug pipeline of small molecule therapeutics, using its proprietary OdyssION TM drug discovery platform. To help their team achieve …See details»
Omass - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 2, 2025 Omass - Offers mass spectrometry related services. Acquired by Syncona. Raised a total funding of $19.3M over 2 rounds from 2 investors. Founded by Idlir Liko and Jonathan …See details»
Member spotlight: Meet OMass Therapeutics | BIA
Mar 18, 2024 Member spotlight: Meet OMass Therapeutics. In this blog, Ros Deegan, CEO of OMass Therapeutics, a member of the BIA Board and a member of the Prime Ministers 2024 …See details»
OMass Therapeutics: New technology for drug ... - University of …
OMass’ work is based on novel mass spectrometry approaches, developed in Professor Dame Carol Robinson’s Laboratory, which enable the study of proteins in the cell membrane (the …See details»
Member profile: OMass Therapeutics | BIA - bioindustry.org
OMass is harnessing native mass spectrometry and other biophysical technologies to drive drug discovery in high definition. The company’s suite of proprietary technologies delivers superior …See details»
PRESS RELEASE OMass Therapeutics Expands Development Team …
OMass Therapeutics ICR Consilium Rosamond Deegan, Chief Executive Officer Phone: +44 (0) 1235 527589 Email: [email protected] Sue Charles / Suki Virji / Kumail Waljee Phone: …See details»
OMass Therapeutics Expands Development Team with Key …
Jan 10, 2024 OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins …See details»
OMASS THERAPEUTICS LIMITED - Companies House
More for OMASS THERAPEUTICS LIMITED (10028228) Officers; Persons with significant control; Persons with significant control: 2 active persons with significant control / 0 active …See details»
UK biotech OMass raises £27.5m for GPCR drug discovery
Feb 18, 2020 Oxford, UK-based OMass Therapeutics has extended its first-round financing to more than £41 million ($53 million), to help it fund the development of drugs that target G …See details»
Jobs - OBN
Oct 10, 2024 OMass Therapeutics is a biotechnology company based in Oxford discovering medicines against highly- validated target ecosystems, such as membrane proteins or …See details»
State of the Global Climate 2024
Supplement: State of Climate Services 2024. Supplement: Significant Weather & Climate Events 2024. The clear signs of human-induced climate change reached new heights in 2024, which …See details»